Lincoln Pharmaceuticals Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹597.00
Market cap
1,196 Cr
Stock P/E
13.5
P/B
1.58
Dividend yield
0.3%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales136 Cr292 Cr438 Cr581 Cr147 Cr308 Cr147 Cr168 Cr154 Cr163 Cr166 Cr187 Cr
Operating expenses (approx.)107 Cr223 Cr329 Cr446 Cr114 Cr237 Cr114 Cr148 Cr115 Cr131 Cr128 Cr167 Cr
EBITDA28 Cr68 Cr109 Cr134 Cr33 Cr71 Cr33 Cr20 Cr39 Cr33 Cr39 Cr21 Cr
OPM %20.9%23.4%24.9%23.1%22.5%23.2%22.3%11.8%25.4%20.0%23.3%11.0%
Other income8 Cr16 Cr27 Cr34 Cr10 Cr20 Cr9 Cr-7 Cr15 Cr7 Cr15 Cr-4 Cr
Interest0.42 Cr0.81 Cr0.97 Cr1 Cr0.44 Cr0.79 Cr0.73 Cr0.37 Cr0.21 Cr0.23 Cr0.30 Cr0.27 Cr
Depreciation3 Cr5 Cr8 Cr11 Cr3 Cr6 Cr3 Cr3 Cr3 Cr4 Cr4 Cr4 Cr
Profit before tax25 Cr62 Cr100 Cr122 Cr29 Cr64 Cr29 Cr16 Cr35 Cr29 Cr35 Cr17 Cr
Tax %25.3%25.1%25.3%23.7%19.7%22.2%27.6%28.8%21.8%30.6%17.6%30.3%
Net profit19 Cr47 Cr75 Cr93 Cr24 Cr50 Cr21 Cr12 Cr28 Cr20 Cr29 Cr12 Cr
EPS (₹)₹9.49₹23.30₹37.30₹46.58₹11.82₹24.96₹10.37₹5.78₹13.82₹9.98₹14.28₹5.81

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales472 Cr510 Cr581 Cr623 Cr671 CrSign in for TTM
Operating expenses (approx.)377 Cr421 Cr481 Cr499 Cr540 CrSign in for TTM
EBITDA95 Cr89 Cr100 Cr124 Cr131 CrSign in for TTM
OPM %20.2%17.5%17.2%19.9%19.5%Sign in for TTM
Other income10 Cr22 Cr34 Cr22 Cr33 CrSign in for TTM
Interest1 Cr2 Cr1 Cr2 Cr1 CrSign in for TTM
Depreciation8 Cr9 Cr11 Cr13 Cr14 CrSign in for TTM
Profit before tax96 Cr100 Cr122 Cr109 Cr116 CrSign in for TTM
Tax %27.7%27.4%23.7%24.6%24.0%Sign in for TTM
Net profit69 Cr73 Cr93 Cr82 Cr88 CrSign in for TTM
EPS (₹)₹34.63₹36.40₹46.58₹41.11₹43.88Sign in for TTM
Dividend payout %4.3%4.1%3.2%4.4%4.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital20 Cr20 Cr20 Cr20 Cr20 Cr
Reserves413 Cr482 Cr573 Cr652 Cr738 Cr
Borrowings2 Cr2 Cr1 Cr—4 Cr
Other liabilities99 Cr83 Cr106 Cr125 Cr128 Cr
Total liabilities534 Cr587 Cr700 Cr797 Cr890 Cr
Fixed assets (net)131 Cr150 Cr179 Cr182 Cr190 Cr
CWIP16 Cr7 Cr3 Cr4 Cr5 Cr
Investments97 Cr91 Cr139 Cr174 Cr209 Cr
Other assets385 Cr390 Cr485 Cr535 Cr664 Cr
Total assets534 Cr587 Cr700 Cr797 Cr890 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity76 Cr39 Cr63 Cr93 Cr106 Cr
Cash from investing-78 Cr-37 Cr-57 Cr-79 Cr-98 Cr
Cash from financing-3 Cr-5 Cr-5 Cr-6 Cr0.16 Cr
Net cash flow-5 Cr-2 Cr0.70 Cr8 Cr8 Cr
Free cash flow (OCF − Capex)31 Cr25 Cr24 Cr74 Cr81 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %20.1%15.9%15.0%16.5%15.3%
ROE %16.0%0.0%0.0%0.0%0.0%
Debtor days8997102——
Inventory days167144140134122
Days payable165105131——
Cash conversion cycle92136110134122
Debt / equity0.00470.00400.0018—0.0058
Current ratio3.905.084.844.715.25
Net debt / EBITDA-0.05-0.03-0.05-0.11-0.13

Compare with peers

Loading peers…